201 related articles for article (PubMed ID: 32953933)
1. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.
Liu X; Hu C
Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of E2F Family Members in Human Gastric Cancer.
Li S; Yang X; Li W; Chen Z
Front Oncol; 2021; 11():625257. PubMed ID: 34532281
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of
Manicum T; Ni F; Ye Y; Fan X; Chen BC
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30487158
[TBL] [Abstract][Full Text] [Related]
4.
Zhou Q; Zhang F; He Z; Zuo MZ
Front Oncol; 2019; 9():161. PubMed ID: 30967995
[No Abstract] [Full Text] [Related]
5. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
[TBL] [Abstract][Full Text] [Related]
6. E2F1/2/4 mRNA is associated with immune infiltration and are potential biomarkers for the prognosis of human gastric carcinoma.
Chen Y; Gong W; Dai W; Jiang H; Xu X
Transl Cancer Res; 2021 Jun; 10(6):2801-2811. PubMed ID: 35116590
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
Front Oncol; 2020; 10():606735. PubMed ID: 33604289
[TBL] [Abstract][Full Text] [Related]
8. E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma.
Yang C; Zhang ZC; Liu TB; Xu Y; Xia BR; Lou G
Cancer Cell Int; 2020; 20():500. PubMed ID: 33061852
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
Li Y; Huang J; Yang D; Xiang S; Sun J; Li H; Ren G
Oncol Lett; 2018 Jun; 15(6):9216-9230. PubMed ID: 29844824
[TBL] [Abstract][Full Text] [Related]
10. Expressions and prognostic values of the
Liu ZL; Bi XW; Liu PP; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
Cancer Manag Res; 2018; 10():3521-3532. PubMed ID: 30271201
[No Abstract] [Full Text] [Related]
11. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.
Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ
Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.
Han Z; Mo R; Cai S; Feng Y; Tang Z; Ye J; Liu R; Cai Z; Zhu X; Deng Y; Zou Z; Wu Y; Cai Z; Liang Y; Zhong W
Front Cell Dev Biol; 2022; 10():831329. PubMed ID: 35531101
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional E2F1/2/3/6 as potential prognostic biomarkers in cutaneous melanoma.
Li J; Shu XL; Shao Q; Luo Q; Diao QC; Zhang X; Sui JD; Guo J; Tao D; Zhou X; Wang Y; Wang C
Am J Transl Res; 2021; 13(1):420-433. PubMed ID: 33527034
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
Hu D; Meng N; Lou X; Li Z; Teng Y; Tu B; Zou Y; Wang F
Int J Gen Med; 2021; 14():3593-3609. PubMed ID: 34295182
[TBL] [Abstract][Full Text] [Related]
15. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.
Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Shao S; Chen X; Chen X
Int J Gen Med; 2022; 15():4849-4870. PubMed ID: 35585998
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
Zhang C; Cui Y; Wang G; Zhao W; Zhao H; Huang X; Zhang M; Li W
J Healthc Eng; 2021; 2021():5790416. PubMed ID: 34531966
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma.
Luo L; Zhang G; Wu T; Wu G
Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547
[TBL] [Abstract][Full Text] [Related]
18. Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.
Liao P; Han S; Qu H
Biomed Res Int; 2020; 2020():6281635. PubMed ID: 33381564
[TBL] [Abstract][Full Text] [Related]
19. Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis.
Liang B; Zhao J; Wang X
Genes Cancer; 2017 May; 8(5-6):600-607. PubMed ID: 28740578
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Expression of
Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
